Smith, DM;
Culme-Seymour, EJ;
Mason, C;
(2018)
Evolving Industry Partnerships and Investments in Cell and Gene Therapies.
Cell Stem Cell
, 22
(5)
pp. 623-626.
10.1016/j.stem.2018.03.004.
Preview |
Text
Smith et al 2018.pdf - Published Version Download (437kB) | Preview |
Abstract
Cell and gene therapies hold the promise of providing significant and durable health gains to patients in many disease states and have recently elicited significant investor and partner interest. We cover the current state of industry partnerships and investments, highlight what makes a partnership advantageous, and discuss implications for stem cell therapies.
| Type: | Article |
|---|---|
| Title: | Evolving Industry Partnerships and Investments in Cell and Gene Therapies |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.stem.2018.03.004 |
| Publisher version: | http://doi.org/10.1016/j.stem.2018.03.004 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10072624 |
Archive Staff Only
 |
View Item |
